[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30709-30710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10891]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors
(BSC), National Center for Injury Prevention and Control (NCIPC). This
meeting is open to the public, limited only by the ports available.
There will be 2,000 telephone ports available. There will be 40 minutes
allotted for oral public comments at the end of the open session from
12:20 p.m. to 1:00 p.m. on July 22, 2020.
The public is encouraged to register to participate by telephone
and/or provide oral public comment using the registration form
available at the link provided: https://www.surveymonkey.com/r/NVV9XM2.
Individuals registered to provide oral public comment will be
called upon to speak based on the order of registration. After persons
who have registered have spoken, any remaining time in the oral public
comment period will be used for members of the public who have not
registered to speak but wish to offer comment. Individuals making oral
public comment during the meeting will have a 2-minute speaking limit
to allow for as many comments as possible.
DATES: The meeting will be held on July 22, 2020, 10:00 a.m. to 1:00
p.m., EDT (OPEN) and July 22, 2020, 1:45 p.m. to 4:15 p.m., EDT
(CLOSED).
ADDRESSES: Teleconference 1-800-369-3110; Participant Code 7563795.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop S106-9, Atlanta, GA 30341, Telephone (770)
488-3953, Email address: [email protected].
SUPPLEMENTARY INFORMATION: Portions of the meeting as designated above
will be closed to the public in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC pursuant to Public Law 92-463.
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The BSC, NCIPC makes
recommendations regarding policies, strategies, objectives, and
priorities; reviews progress toward injury prevention goals; and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, as well as the structure, progress and
performance of intramural programs. The Board is designed to provide
guidance on extramural scientific program matters, including the: (1)
Review of extramural research concepts for funding opportunity
announcements; (2) conduct of Secondary Peer Review of extramural
research grants, cooperative agreements, and contracts applications
received in response to the funding opportunity announcements as they
relate to the
[[Page 30710]]
Center's programmatic balance and mission; (3) submission of secondary
review recommendations to the Center Director of applications to be
considered for funding support; (4) review of research portfolios; and
(5) review of program proposals.
Matters To Be Considered: The open portion of the agenda will
include an update on the formation of the BSC, NCIPC Opioid Workgroup,
a presentation focused on opportunities for stakeholder engagement on
management of acute and chronic pain, and an update on the CDC Opioid
Prescribing Estimates Project. All presentations will be followed by
discussion by the BSC. The closed portion of the agenda will focus on
the secondary peer review of extramural research grant applications
received in response to two (2) Notice of Funding Opportunities
(NOFOs): RFA-CE20-001--``Evaluating Practice-Based Programs, Policies,
and Practices from CDC's Rape Prevention and Education (RPE) Program:
Expanding the Evidence to Prevent Sexual Violence''; and RFA-CE20-003--
``Research Grants for Preventing Violence and Violence-Related Injury''
(R01). Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, CDC, has been delegated the authority to sign
Federal Register notices pertaining to announcements of meetings and
other committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and Disease
Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10891 Filed 5-19-20; 8:45 am]
BILLING CODE 4163-18-P